Participants having received both COVID-19 vaccine inoculations are still becoming infected with COVID-19 virus.

Participants having received both vaccine inoculations can still become infected and spread the virus.

Participants having received vaccines are being hospitalized and dying.

Renowned virologists, including a Nobel laureate who discovered the HIV virus had warned that introducing a vaccine in the midst of a pandemic will result in immune escape resulting in increased mutations and variants. This is now the case. It has been stated that vaccinated patients presenting to the hospital with COVID-19 infection likely have been infected with a variant strain.

There are no tests to confirm or refute whether a patient who may have had an adverse event was due to the vaccination. Therefore, most adverse events are being labeled coincidental and unrelated.

All other mandated vaccines have decades long clinical data demonstrating safety. The clinical data available on the COVID vaccines is 7 months in duration and the normal extremely stringent protocol for following subjects is non-existent. It is shameful for anyone to insinuate that the follow-up of subjects in this clinical trial is in line with any clinical trial ever performed with human subjects.

There is fear amongst the medical community regarding the possible long term effects of SARS-CoV-2 infection. There is seemingly no concern about the long-term effects of the COVID-19 vaccine. After months of lax clinical trials, It is constantly stated there are no long-term adverse effects. The claim that there are no long-term effects flies in the face of all logic.

As of May 11th, 2021, it was stated by Drs Fauci, Walensky and Marks of the NIAID, FDA and CDC respectively during a Senate hearing that 40% of their employees have not been vaccinated.

For influenza, a person granted an exemption from receiving the flu shot is permitted to wear a surgical mask during patient encounters during the flu season. No such exemptions are provided for those who do not wish to be part of this Phase 3 study of investigational vaccine.

An extremely important aspect of medication classification is the FDA Pregnancy Categories. Category A through Category D and Category X. Category A is safe in pregnancy and Category X shows significant fetal abnormalities and/or positive evidence of human fetal risk and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits. Penn Medicine initially was adamant that this vaccine is completely safe in pregnancy and many pregnant employees received the vaccine. However, recently the policy has changed and now it's not required during pregnancy, but the employee needs to be vaccinated before returning to work.

Will the antibodies against the spike protein encoded by the mRNA and/or the spike protein itself be transmitted into the mother's milk and what are the short and long-term effects on the breastfeeding infant? There are reports of miscarriages and deaths of breastfeeding infants.

No studies have been performed to determine whether this experimental vaccine results in infertility.

No studies have been done to assess cancer risk from exposure to this vaccine or any of its other ingredients.

A component found within the ingredients of the COVID vaccines is SM-102. The OSHA HCS listing is as follows: This product is for research use - Not for human or veterinary diagnostic or therapeutic use. It is the responsibility of the purchaser to determine suitability for other applications. GHS08 Health Hazard lists 1) Carcinogen. 2H351 Suspected of causing cancer. 2) Reproductive. 2H361 Suspected of damaging fertility or the unborn child. 3) STOT RE 1H372 Causes damage to the central nervous system, the kidneys, the liver and the respiratory system through prolonged or repeated exposure. There are no other medications currently on the market that contain this ingredient.

The 2008 Nobel laureate Dr. Luc Montagnier who discovered the HIV virus in 1983 and renowned virologist and vaccine developer Dr Geert Vander Bossche state that these new vaccines are extremely effective to prevent disease but not treat infection. They are to be used for prophylaxis but should not be used under high infectious pressure. Being very specific and with strong binding affinity this outcompetes the natural immunity which has low affinity and broad spectrum. These virologists emphatically state that introducing a vaccine during a pandemic will result in immune escape. Their contention was that such a scenario would result in a high number of mutations and variants. Many in the science community did all they could to discredit these two doctors. This is in fact what happened.

The data reported that assigned 95% effectiveness of the Pfizer vaccine had 43,548 trial participants. However, their calculation of effectiveness is based on ONLY a total of 170 participants. These 170 participants were the first to develop symptoms of COVID and test positive for SARS-CoV-2. 162 of them were placebo recipients and 8 were vaccine recipients. This is where the “95% effective” calculation comes from. However, the rest of the participants were not tested for infection, nor were they tested for the development of antibodies, which is the endpoint typically used to measure vaccine effectiveness. Since we now know that there are many asymptomatic COVID positive people following vaccination, had they tested all of the 43,548 participants, the efficacy would certainly be much lower.

The announcement on the front page of the Lancaster newspaper of the mandatory requirement to receive an experimental vaccine as terms of employment at Penn Medicine along with the fact that Penn Medicine had developed the vaccine and therefore they were confident it was safe and subsequently could compel their employees to receive this vaccine is certainly biased and would seem to be a conflict of interest.

Penn Medicine providers are instructed to not give lab slips to assess for natural (N) antibodies but rather insist on administering COVID vaccine. However, The Lancet vol 397:10283 demonstrates that natural immunity confers 84% lower risk of infection with J&J vaccine only 66.3% effective.

Penn Medicine providers are persuaded not to give any medical exemptions for the COVID-19 vaccine since the constant mantra is that the vaccine is safe in every person, at every age and every condition or disease process.

Initially when these vaccines were introduced, the pharmaceutical companies published press releases stating that mRNA is not new science and that, in fact, it has been around for decades in the research for cancer treatment. These press releases went on to say that while the cancer research was promising in the laboratory, in clinical trials it was not effective. Protocols used for cancer such as chemotherapy and radiation would never be considered for a healthy population.

An article published by the National Center for Biotechnology Information, a division of the National Institutes of Health, said other risks of COVID-19 vaccine include the bio-distribution and persistence of the induced immunogen expression; possible development of auto-reactive antibodies; and toxic effects of any non-native nucleotides and delivery system components. We are concerned about this as well.

Some people considering the vaccine are on a variety of medications for oncological, autoimmune, or chronic inflammatory disorders. These medications may include a combination of Rituximab, Methotrexate, Prednisone, Dexamethasone, Hydroxychloroquine, TNF blockers, IL-blockers, JAK blockers, etc. No research studies are available that speak to the percentage of efficacy of the Covid-19 vaccine for people on these immune modifying or immune blocking medications and is it possible that people with these conditions will have a diluted antibody response to the vaccine.

The Constitution of the United States does not end at the door of your institution. Citizens of United States still have the right to refuse being injected with annything and not be coerced to do so at great expense of money and their livelihood.